BGV focuses on earlystage European biotech, medtech, and diagnostics companies, aiming to support innovations that address unmet medical needs and demonstrate significant proof of concept. They partner with scientists and entrepreneurs to build new companies, guiding them from early stages through clinical trials to successful exits.